Cargando…
BTC as a Novel Biomarker Contributing to EMT via the PI3K-AKT Pathway in OSCC
Purpose: Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors of the head and neck, while metastasis is the main cause of OSCC-related death. There is an urgent need to explore novel prognostic biomarkers and identify biological targets related to metastasis in OSCC treatme...
Autores principales: | Shen, Ting, Yang, Tianru, Yao, Mianfeng, Zheng, Ziran, He, Mi, Shao, Mengying, Li, Jiang, Fang, Changyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283838/ https://www.ncbi.nlm.nih.gov/pubmed/35846125 http://dx.doi.org/10.3389/fgene.2022.875617 |
Ejemplares similares
-
HNRNPA2B1, as a m(6)A Reader, Promotes Tumorigenesis and Metastasis of Oral Squamous Cell Carcinoma
por: Zhu, Feiya, et al.
Publicado: (2021) -
DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC
por: Sun, Yang, et al.
Publicado: (2022) -
The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway
por: Wang, Jie, et al.
Publicado: (2020) -
THBS1-Mediated Degradation of Collagen via the PI3K/AKT Pathway Facilitates the Metastasis and Poor Prognosis of OSCC
por: Wen, Zhihao, et al.
Publicado: (2023) -
M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT
por: Huang, Guang-Zhao, et al.
Publicado: (2020)